HCS HB 1534 -- LIFE SCIENCES RESEARCH (Lembke)

COMMITTEE OF ORIGIN:  Health Care Policy

This substitute requires 25% of the funds received from
subsequent participating manufacturers in the Tobacco Settlement
Agreement that are deposited into the Life Sciences Research
Trust Fund to be expended by the Life Sciences Research Board.
The board is required to spend 25% of the moneys in the trust
fund for the program that awards grants to establish and expand
umbilical cord blood banks.  The remaining 75% must fund life
science research projects involving the study, use, or therapies
involving human stem cells derived from non-embryonic and
non-fetal sources.

FISCAL NOTE:  No impact on state funds in FY 2007, FY 2008, and
FY 2009.

Missouri House of Representatives
93rd General Assembly, 2nd Regular Session
Last Updated November 29, 2006 at 9:43 am